tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Apellis appoints Mikael Dolsten to board of directors
PremiumThe FlyApellis appoints Mikael Dolsten to board of directors
3d ago
Pfizer, Astellas announce results from Phase 3 EV-304 trial for PADCEV
Premium
The Fly
Pfizer, Astellas announce results from Phase 3 EV-304 trial for PADCEV
6d ago
Private Markets: World Labs raises $1B in new funding
Premium
The Fly
Private Markets: World Labs raises $1B in new funding
7d ago
RBC starts Pfizer at Underperform on ‘insurmountable’ patent cliff
PremiumThe FlyRBC starts Pfizer at Underperform on ‘insurmountable’ patent cliff
9d ago
Pfizer initiated with an Underperform at RBC Capital
Premium
The Fly
Pfizer initiated with an Underperform at RBC Capital
9d ago
FDA grants traditional approval to encorafenib for CRC with BRAF V600E mutation
Premium
The Fly
FDA grants traditional approval to encorafenib for CRC with BRAF V600E mutation
9d ago
FDA to begin requiring on clinical trial
PremiumThe FlyFDA to begin requiring on clinical trial
15d ago
FDA to begin requiring one clinical trial in drug approvals
Premium
The Fly
FDA to begin requiring one clinical trial in drug approvals
15d ago
Mixed options sentiment in Pfizer with shares down 0.2%
Premium
The Fly
Mixed options sentiment in Pfizer with shares down 0.2%
15d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100